Chief Medical Officer

The Chief Medical Officer is a pivotal Executive Board role, providing vision, professional leadership and strategic direction in the delivery of the Trust's ambitions in the provision of care, learning and research. The Chief Medical Officer will apply their clinical and wider leadership skills and experience, together with curiosity in service of driving great care, teaching and research.
The post holder provides strong and effective clinical and medical leadership and engagement within the organisation and across professional boundaries and takes lead responsibility for the medical implications of clinical service strategy, service configuration, clinical performance, governance and professional conduct.
The Chief Medical Officer maintains effective working relationships with the Trust's academic and healthcare partners. The post holder also champions the Trust's status as a leading University teaching hospital and major centre for research and
development and is responsible for leading a portfolio of responsibilities. These change from time to time and currently includes for example infection prevention control (the CMO being the Director of Infection, Prevention
and Control (DIPC), clinical audit, medicines management and medical education, Patient safety, quality & improvement and operational performance
Provide professional clinical leadership to all Medical and Dental staff, championing the participation and engagement of
clinical leaders in the management and delivery of effective and efficient care, learning and research.
Ensure effective relationships are maintained between the Trust and Deanery/NHS England (post-graduate medical
education), and University of Cambridge Clinical School (undergraduate medical education).
Lead, from a medical perspective, the development of new models of care, fit for the future, that put patient need at the
centre, harness new technology and work collaboratively with professionals in and outside the hospital
Lead and promote the Trust's research and development agenda internally and externally, ensuring that high quality
research is able to flourish and is aligned with the strategic ambitions of the organisation.
Develop and maintain effective working relationships with external agencies and the local community, including
commissioning bodies, GPs, local politicians, health organisations, interest groups, patient reference groups, the Shelford
Group, and the local media., We are situated on the Cambridge Biomedical Campus, the largest centre of life science and medical research in Europe, and aspire to develop cross-industry partnerships that further improve outcomes for patients while powering economic growth through working with some of the greatest minds in the country on cutting edge research which can then directly impact patient care. Building for the future is an essential part of our strategy, and we see this coming to fruition through our exciting plans for the development of new Cancer and Children's hospitals.

Cambridge University Hospitals (CUH) is an internationally renowned healthcare organisation and one of the largest and highest profile NHS teaching hospitals in the country. We deliver expert care for patients while our vibrant teaching community equips and empowers the healthcare leaders of tomorrow. CUH - Addenbrooke's and The Rosie - is a team of over 13,000 people and a range of partners who are passionate about improving people's lives. We have an annual budget of over £1.5bn and provide services as a local hospital for people in Cambridge, South and East Cambridgeshire, and as a specialist hospital for a wider population. As an academic medical centre we work across 75 medical and surgical specialties, with corporate and support teams - and health, care, academic and industry partners - to deliver care, learning and research in support of our vision of a healthier life for everyone.

Selected candidates will be invited to attend preliminary interviews with Odgers Berndtson in December and January.
The final interview process with CUH will take place on a date to be confirmed in January.